Human gastric, colorectal, and renal carcinomas constitutively express both IDO1 and IDO2 (6, 14), as well as brain tumors, such as gliomas and meningiomas (15), and pancreatic ductal adenocarcinomas, in which IDO2 appears to be overexpressed (16). This evidence concerns the gene IDO2 and glioma.